NAIM BIDEIWY: Open Payments
NPI 1235777426 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,364 in 19 payments from 8 companies in 2025. Trend: 2023 $793 · 2024 $782 · 2025 $1,364
Food & beverage: $990Education: $199Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 4 | $329 |
| Janssen Biotech, Inc. | 5 | $315 |
| Legend Biotech USA Inc. | 2 | $267 |
| ABBVIE INC. | 4 | $151 |
| Karyopharm Therapeutics Inc. | 1 | $125 |
| SpringWorks Therapeutics, Inc. | 1 | $122 |
| GENZYME CORPORATION | 1 | $32 |
| SANOFI-AVENTIS U.S. LLC | 1 | $24 |
Products named: CARVYKTI, ELREXFIO, RYBREVANT, XPOVIO, OGSIVEO, IMBRUVICA, DARZALEX, EPKINLY.
Industry payments across NY — which companies pay providers there.
